Essity


A well-balanced health and hygiene proposition

08/01/19 -"Recommendation and upside We are initiating coverage of Essity (market cap: SEK152bn/€15bn and free float: 91%) with an ‘Add’ recommendation and a target price of SEK229 per share (5.5% upside). Our ..."

Pages
46
Language
English
Published on
08/01/19
You may also be interested by these reports :
12/07/19
We have factored in the one-off impact from the $1.4bn (will lead to $1.1bn or ₤880m charge in H1 19) settlement that RB has managed with the DOJ ...

08/07/19
... was just in time, from our point of view! As a reminder, the Q1 figures (see Latest of 07/05/2019) were not primarily a source of joy as the ...

24/06/19
Someone is missing and the world falls apart. This seems the case for Henkel  (Add, Germany) which has been on a steady decline since Mr Rorsted left ...

22/05/19
We have upgraded our estimates following the stronger than expected Q1 2019 numbers. Given the incremental price increases planned for 2019, and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO